Market Cap 60.55M
Revenue (ttm) 0.00
Net Income (ttm) -21.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 173,100
Avg Vol 222,624
Day's Range N/A - N/A
Shares Out 28.83M
Stochastic %K 23%
Beta 0.25
Analysts Sell
Price Target $7.00

Company Profile

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was in...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 651 8041
Address:
11400 West Olympic Boulevard, Suite 200, Los Angeles, United States
PMtrader_92
PMtrader_92 Sep. 16 at 9:13 PM
$IMMX company not competitive enough in an already very competitive space
1 · Reply
Xan16
Xan16 Sep. 16 at 7:52 PM
$IMMX Under $2 is not good. Selling pressure is winning the battle.
1 · Reply
keebs107
keebs107 Sep. 16 at 7:08 PM
0 · Reply
PokerMunkee
PokerMunkee Sep. 16 at 1:09 AM
$IMMX PR tomorrow pre market? 🤔
0 · Reply
keebs107
keebs107 Sep. 15 at 5:10 PM
0 · Reply
billywilliamz
billywilliamz Sep. 12 at 6:18 PM
$IMMX garbage
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 12 at 12:40 PM
$IMMX Cheers!!
0 · Reply
RetiredLife_45
RetiredLife_45 Sep. 12 at 12:08 PM
$IMMX https://finance.yahoo.com/news/nancy-t-chang-proven-biotechnology-131500566.html
0 · Reply
JarvisFlow
JarvisFlow Sep. 12 at 11:30 AM
HC Wainwright & Co. updates rating for Immix Biopharma ( $IMMX ) to Buy, target set at 7 → 8.
0 · Reply
Daddy044
Daddy044 Sep. 11 at 5:31 PM
$IMMX New Director is pretty good
0 · Reply
Latest News on IMMX
Immix Biopharma Announces Other Serious Diseases Strategy

Aug 6, 2025, 12:30 PM EDT - 5 weeks ago

Immix Biopharma Announces Other Serious Diseases Strategy


Immix Biopharma Attends FDA CEO Forum in Washington DC

Jun 6, 2025, 9:39 AM EDT - 3 months ago

Immix Biopharma Attends FDA CEO Forum in Washington DC


Immix Biopharma 12 Month Review Progress Update

Feb 21, 2024, 9:31 AM EST - 1 year ago

Immix Biopharma 12 Month Review Progress Update


PMtrader_92
PMtrader_92 Sep. 16 at 9:13 PM
$IMMX company not competitive enough in an already very competitive space
1 · Reply
Xan16
Xan16 Sep. 16 at 7:52 PM
$IMMX Under $2 is not good. Selling pressure is winning the battle.
1 · Reply
keebs107
keebs107 Sep. 16 at 7:08 PM
0 · Reply
PokerMunkee
PokerMunkee Sep. 16 at 1:09 AM
$IMMX PR tomorrow pre market? 🤔
0 · Reply
keebs107
keebs107 Sep. 15 at 5:10 PM
0 · Reply
billywilliamz
billywilliamz Sep. 12 at 6:18 PM
$IMMX garbage
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 12 at 12:40 PM
$IMMX Cheers!!
0 · Reply
RetiredLife_45
RetiredLife_45 Sep. 12 at 12:08 PM
$IMMX https://finance.yahoo.com/news/nancy-t-chang-proven-biotechnology-131500566.html
0 · Reply
JarvisFlow
JarvisFlow Sep. 12 at 11:30 AM
HC Wainwright & Co. updates rating for Immix Biopharma ( $IMMX ) to Buy, target set at 7 → 8.
0 · Reply
Daddy044
Daddy044 Sep. 11 at 5:31 PM
$IMMX New Director is pretty good
0 · Reply
Dingalingading
Dingalingading Sep. 11 at 2:45 PM
0 · Reply
Hayer1900
Hayer1900 Sep. 11 at 1:12 AM
0 · Reply
PMtrader_92
PMtrader_92 Sep. 10 at 6:26 PM
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 10 at 2:00 AM
$IMMX Why a Viral Vector Engineer now? Bullish signal: Expanding scientific staff shows they’re not just coasting on their lead assets but are committing capital to R&D growth. Costs: Hiring specialists in Sacramento, CA is not cheap. This is a small financial headwind (higher R&D spend, burn rate) but a long-term positive if it strengthens pipeline credibility. Partnership potential: Companies often hire vector engineers when anticipating collaborations with academic groups or biotech partners who need vector design expertise. this job posting is probably an early tell of something bigger in the pipeline—they wouldn’t spend money building in-house viral vector expertise unless they planned to show investors that Immix has a scalable gene therapy play.
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 10 at 1:53 AM
$IMMX New job post. Seems a bit off brand. They wouldn’t spend money building in-house viral vector expertise unless they planned to show investors that Immix has a scalable gene therapy play. They’re hiring for a Viral Vector Engineer Scientist, which is directly tied to gene transfer technologies. This indicates Immix is actively building out capabilities in gene therapy and cell therapy manufacturing, not just small molecules or biologics.
0 · Reply
Dingalingading
Dingalingading Sep. 9 at 10:45 PM
$IMMX 🐴Mr. Ed: IMMX Update: Goose flew in, Nancy saddled up, and this biotech pony’s got pep! Price: $2.32 (+4.84%) After-hours: $2.36 (+1.98%) Volume: 182K 52W Range: $1.26 – $3.20 Market Cap: $65.6M P/E: –2.74 Not bad for a Tuesday trot. Hay’s on me. 🐎💸 🦢 Goose Capital + Dr. Nancy Chang = Biotech Boost IMMX just locked in a strategic investment from Goose Capital and biotech legend Nancy Chang (sold Tanox to Genentech for $919M). She’s now on the board. Placement came in ABOVE market at $2.37. That’s not just bullish—it’s barn-storming. 🧪 Clinical Trail Watch: Primary endpoint met ✅ $11M cash + $5.6M potential from warrants BLM submission pending Buyout whispers: $450M$1B if data delivers Stocktwits Mood: Bulls: “Long and strong, biotech belongs!” Bears: “Sub-$2 coming, saddle up for pain.” Mr. Ed: “I just want Nancy to autograph my hoof.” Final Neigh: If this pony keeps pace and the data drops clean, we’re not just riding—we’re galloping. 🐎💨
0 · Reply
ComradeKomisar
ComradeKomisar Sep. 9 at 7:47 PM
$IMMX $CVM $EBS Bangor 🫡
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 9 at 7:44 PM
$IMMX Thinking news tomorrow too! Cheers
1 · Reply
tooquarters
tooquarters Sep. 9 at 7:23 PM
$IMMX $CVM $EBS As we check in on our insecure boy hero IMMXBELIEVER/ SUSHIFISHMANNEW/ WHATEVER, we are witnessing first hand his uncanny ability to “foretell” news by incessantly repeating the same predictions week after week until something, anything, is announced to “vindicate” his oft used strategy. Now that IMMX has finally announced some news, albeit benign and hardly “needle moving”, he is treating his gullible Boba tea followers to enthusiastic proclamations of victory while hopping up and down and soiling himself in glee. And not to worry, he will generously share his flaccid spectacle on all of these message boards, relevant or not, for the amusement of all. Congratulations little fella! Keep up the good work...you are truly the novelty gift that keeps giving!
1 · Reply
billywilliamz
billywilliamz Sep. 9 at 6:53 PM
$IMMX this stock no bueno, going sub2$
0 · Reply
ImmxBeliever
ImmxBeliever Sep. 9 at 4:23 PM
$IMMX is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that it has received a strategic investment from Goose Capital and former Tanox, Inc. CEO Dr. Nancy T. Chang, Goose founding member. https://www.pressviewer.com/ViewEmail.asp?b=2649&id=363404&p=2399921&I=1447114-X3L4J7h4a7
0 · Reply
Dingalingading
Dingalingading Sep. 9 at 2:57 PM
0 · Reply